Showing 401 - 420 results of 3,189 for search '"vaccination"', query time: 0.06s Refine Results
  1. 401

    Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses by Hiam Chemaitelly, Laith J Abu-Raddad, Houssein H Ayoub, Susanne F Awad, Monia Makhoul

    Published 2024-05-01
    “…New approaches are needed to control CT disease burden.Methods An age-structured deterministic mathematical model calibrated to nationally representative population-based data was developed to investigate the impact of CT vaccination on the population of the USA if a vaccine becomes available. …”
    Get full text
    Article
  2. 402

    Assessing the Role of Vaccination in the Control of Hand, Foot, and Mouth Disease Transmission by Zuhur Alqahtani, Mahmoud H. DarAssi, Yousef AbuHour, Areej Almuneef

    Published 2025-01-01
    “…This model provides vaccination strategies and characterizes local and global stability using Lyapunov functions. …”
    Get full text
    Article
  3. 403
  4. 404

    Methods of saponin purification from Quillaja sp. for vaccine adjuvant production by Victor Morais, Norma Suarez, Fernando Silveira

    Published 2025-01-01
    “…The adjuvant properties of saponins were known many years ago, but only in recent years have saponins been approved for human vaccine use in this manner. Saponins from Quillaja saponaria bark are the only source of approved preparations for human use, but a related species, Quillaja brasiliensis, also contains similar saponin compositions that can be obtained from leaves. …”
    Get full text
    Article
  5. 405

    Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination by Mathias Vormehr, Barbara Schrörs, Sebastian Boegel, Martin Löwer, Özlem Türeci, Ugur Sahin

    Published 2015-01-01
    “…Preclinical and early clinical data suggest that synthetic mRNA can serve as potent drug format allowing the cost efficient production of highly efficient vaccines in a timely manner. In this review, we describe a process, which integrates next generation sequencing based cancer mutanome mapping, in silico target selection and prioritization approaches, and mRNA vaccine manufacturing and delivery into a process we refer to as MERIT (mutanome engineered RNA immunotherapy).…”
    Get full text
    Article
  6. 406
  7. 407

    A Bicriteria Model to Determine Pareto Optimal Pulse Vaccination Strategies by Funda Samanlioglu, Nauman Tabassum, Tolga Kudret Karaca, Ayse Humeyra Bilge

    Published 2024-01-01
    “…Pulse vaccination is the application of the vaccination campaign over a limited time interval, by vaccinating susceptible individuals at a constant vaccination rate. …”
    Get full text
    Article
  8. 408
  9. 409
  10. 410
  11. 411

    Covid-19 vaccine acceptance and hesitancy among medical students of Faisalabad by Mohi Ud Din, Umer Shahid, Abdul Qudoos, Roman Ahmed, Muazzama Sohail, Saima Javed

    Published 2023-06-01
    “…Results: More than half of the participants i.e. 214 (54.7) have got Sinopharm vaccine. Vaccine hesitancy was found in 28 (7.2%) students and major reason was concern about vaccine safety. …”
    Get full text
    Article
  12. 412

    An Overview of Live Attenuated Recombinant Pseudorabies Viruses for Use as Novel Vaccines by Bo Dong, Dante S. Zarlenga, Xiaofeng Ren

    Published 2014-01-01
    “…In this paper, we review the current status of live attenuated recombinant PRVs and live PRV-based vector vaccines with potential for controlling viral infections in animals.…”
    Get full text
    Article
  13. 413
  14. 414

    Potential Usefulness of Streptococcus pneumoniae Extracellular Membrane Vesicles as Antibacterial Vaccines by Chi-Won Choi, Edmond Changkyun Park, Sung Ho Yun, Sang-Yeop Lee, Seung Il Kim, Gun-Hwa Kim

    Published 2017-01-01
    “…Bacterial EMVs have recently become the focus of attention because of their potential as highly effective vaccines that cause few side effects. Here, we isolated the EMVs of Streptococcus pneumoniae and examined their potential as new vaccine candidates. …”
    Get full text
    Article
  15. 415
  16. 416
  17. 417

    Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine. by Shi-Hsia Hwa, Yock Ann Lee, Joseph N Brewoo, Charalambos D Partidos, Jorge E Osorio, Joseph D Santangelo

    Published 2013-11-01
    “…A toxicology study of the vaccine formulations planned for human use performed in rabbits showed no vaccine-related pathological changes and all animals remained healthy. …”
    Get full text
    Article
  18. 418

    Global Dynamics of an SVEIR Model with Age-Dependent Vaccination, Infection, and Latency by Rodrigue Yves M’pika Massoukou, Suares Clovis Oukouomi Noutchie, Richard Guiem

    Published 2018-01-01
    “…In this paper, we propose an SVEIR epidemic model with age-dependent vaccination, latency, and infection. The model also considers that the waning vaccine-induced immunity depends on vaccination age and the vaccinated individuals fall back to the susceptible class after losing immunity. …”
    Get full text
    Article
  19. 419
  20. 420

    The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation by Liuye Huang, Yuan Yang, Yu Kuang, Dapeng Wei, Wanyi Li, Qin Yin, Juan Pang, Zhongwei Zhang

    Published 2016-01-01
    “…Conclusions. T cell vaccination is helpful in alleviating and regulating systemic lupus erythematosus manifestation.…”
    Get full text
    Article